cholecystokinin-pentapeptide and Alzheimer-Disease

cholecystokinin-pentapeptide has been researched along with Alzheimer-Disease* in 1 studies

Other Studies

1 other study(ies) available for cholecystokinin-pentapeptide and Alzheimer-Disease

ArticleYear
Cholecystokinin peptides and receptor binding in Alzheimer's disease.
    Journal of neural transmission (Vienna, Austria : 1996), 1996, Volume: 103, Issue:7

    Cholecystokinin (CCK) is a peptide that can be found in the cerebral cortex in high concentrations and is involved in learning and memory as well as neurodegenerative processes. Cortical brain samples from 9 patients with Alzheimer's disease and 9 matched control cases were studied with respect to the concentrations of various molecular forms of CCK and the CCK receptor binding characteristics. No differences were found between patients and controls in any of these measures. Significant correlations were found between the concentrations of CCK-8 sulphated and the three nonsulphated CCK peptides measured. In addition, the concentrations of CCK-4 and CCK-5 showed a highly significant and positive correlation.

    Topics: Age of Onset; Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Case-Control Studies; Cholecystokinin; Female; Gyrus Cinguli; Humans; Linear Models; Male; Middle Aged; Peptide Fragments; Receptors, Cholecystokinin; Sincalide; Tetragastrin

1996